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Abstract 
Background: The six-carbon circular non-proteinogenic compound l-pipecolic acid is an important chiral drug inter-
mediate with many applications in the pharmaceutical industry. In the present study, we developed a metabolically 
engineered strain of Escherichia coli for the overproduction of l-pipecolic acid from glucose.
Results: The metabolic pathway from l-lysine to l-pipecolic acid was constructed initially by introducing lysine 
cyclodeaminase (LCD). Next, l-lysine metabolic flux from glucose was amplified by the plasmid-based overexpression 
of dapA, lysC, and lysA under the control of the strong trc promoter to increase the biosynthetic pool of the precur-
sor l-lysine. Additionally, since the catalytic efficiency of the key enzyme LCD is limited by the cofactor NAD+, the 
intracellular pyridine nucleotide concentration was rebalanced by expressing the pntAB gene encoding the tran-
shydrogenase, which elevated the proportion of LCD with bound NAD+ and enhanced l-pipecolic acid production 
significantly. Further, optimization of Fe2+ and surfactant in the fermentation process resulted in 5.33 g/L l-pipecolic 
acid, with a yield of 0.13 g/g of glucose via fed-batch cultivation.
Conclusions: We expanded the metabolic pathway for the synthesis of the chiral pharmaceutical intermediate 
l-pipecolic acid in E. coli. Using the engineered E. coli, a fast and efficient fermentative production of l-pipecolic acid 
was achieved. This strategy could be applied to the biosynthesis of other commercially and industrially important 
chiral compounds containing piperidine rings.
Keywords: Chiral intermediate biosynthesis, Lysine cyclodeaminase, l-Pipecolic acid, Metabolic engineering, 
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Background
Chirality plays a key role not only in the life of plants 
and animals but also in the pharmaceutical, agricultural 
and chemical industries [1, 2]. Particularly, in the phar-
maceutical industry, 56% of all drugs currently in use are 
chiral and screening and production of single enantiom-
ers of chiral intermediates is increasingly important [3]. 
l-pipecolic acid (l-PA) is a non-proteinogenic compound 
and key chiral intermediate in the synthesis of many 
important groups of drugs [4] (Fig. 1). l-PA with a high 
optical purity is a precursor for the anaesthetics ropiv-
acaine, bupivacaine and chloroprocaine which are widely 
used in local anaesthesia [5]; and it is also a precursor 
for the macrolide-pipecolate immunosuppressor rapa-
mycin, FK-506 and FK-520 that are indispensable in the 
clinic [6]. Similar to the preparation of most of the other 
enantiomeric organic compounds, pure l-pipecolic acid 
enantiomers are mainly produced by chemical enantiose-
lective synthesis [7] and stereoselective transformation 
[8]. However, the chemical methods for commercial-
scale preparation of l-PA are complex and environmen-
tally unfriendly [9].
Total biosynthesis of chiral drug intermediates is a 
more environmentally friendly approach for the prepara-
tion of affordable pharmaceuticals [10]. Bioproduction of 
Open Access
Microbial Cell Factories
*Correspondence:  kqchen@njtech.edu.cn 
†Hanxiao Ying and Sha Tao contribute equally to this work
2 College of Biotechnology and Pharmaceutical Engineering, Nanjing 
Tech University, Nanjing 211816, People’s Republic of China
Full list of author information is available at the end of the article
Page 2 of 11Ying et al. Microb Cell Fact  (2017) 16:52 
l-PA has been extensively investigated, mainly due to its 
close relationship with l-lysine metabolism [11, 12]. Pre-
vious studies [11–13] have established two basic routes 
for converting l-lysine to l-PA. The first involves the loss 
of the α-amino group of l-lysine and incorporation of the 
ε-nitrogen into l-pipecolic acid (P2C pathway). The sec-
ond involves the loss of the ε-nitrogen and incorporation 
of an α-nitrogen into l-PA (P6C pathway). Several stud-
ies on the enzymatic production of l-PA using enzymes 
from both pathways have been reported [14, 15]. For 
example, Neshich et al., obtained l-pipeclic acid on lysine 
containing medium (about 0.6  μg/mg protein) using 
recombinant E. coli cells over-expressing the l-lysine 
6-dehydrogenase gene in P6C pathway [16]; Fujii et  al. 
reported that about 3.9  g/L of optically pure l-PA was 
biosynthesised using the enzymes from the P2C pathway 
[17]. Recently, studies on the biosynthesis of rapamycin 
in Streptomyces hygroscopicus found that lysine cyclode-
aminase (LCD) could directly catalyse the conversion of 
l-lysine to l-PA in one step [18]. In our previous stud-
ies, recombinant E. coli over-expressing LCD could pro-
duce l-PA from l-lysine with a yield of nearly 70% [19]. 
In comparison with the P2C and P6C pathways, the LCD 
pathway has many advantages, not least its simplicity, 
and this makes it more suitable for combining with com-
plicated upstream metabolism processes.
The use of purified enzymes or cells as catalysts is often 
limited by high cost and recycling-associated problems 
[20]. Compared with traditional catalytic processes, 
fermentation can simplify the production procedures, 
potentially lowering cost and improving efficiency [21]. 
Very recently, Wendisch et  al. described a fermentation 
method for the production of l-PA from glucose via the 
P6C pathway that include two enzymes and a spontane-
ous chemical reaction in Corynebacterium glutamicum, 
achieving a l-PA titer of 14  mM (1.73  g/L) [22]. Given 
the complexity if the l-PA biosynthesis pathway (P6C), it 
may be possible to improve this method considerably.
In the present study, we developed a new strategy for 
fermentative l-PA production from glucose. Recombi-
nant E. coli expressing lysine cyclodeaminase was con-
structed followed by the increasing of the precursor 
l-lysine flux. In addition, the concentration of intracel-
lular cofactors was rebalanced by overexpressing tran-
shydrogenases, which improved the catalytic efficiency of 
the key lysine cyclodeaminase enzyme. Finally, optimiza-
tion of the fermentation conditions resulted in the high-




Strains and plasmids are summarized in Additional file 1: 
Table S1. All engineered constructs were verified by colony 
PCR and Sanger sequencing. The detailed pathway con-
struction procedure is described in the Additional file 1.
Fig. 1 The structures of pipecolate derivatives. The chemical structures of pipecolate derivatives including (1) rapamycin, (2) FK-506, (3) meridamy-
cin, (4) ropivacaine, (5) nocardiopsin. The pipecolate groups are represented in red
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Media and cultivation conditions
The E. coli seed cultures were grown in Luria–Bertani 
(LB) medium. The recombinant strains used to confirm 
l-lysine and l-pipecolic acid production ability were cul-
tured in the minimal medium containing: 10 g/L glucose, 
17.1 g/L Na2HPO4·12H2O, 0.5 g/L NaCl, 3.0 g/L K2HPO4, 
10  g/L NH4Cl, 0.22  g/L CaCl2, 2.4  g/L MgSO4, and 
0.01 g/L FeSO4. Recombinant strains used to investigate 
the effect of pntAB and fermentation supplements were 
cultured in the modified LB medium containing 5  g/L 
glucose, 5  g/L tryptone, 4  g/L yeast extract, and 10  g/L 
MOPS. Recombinant strains used for fed-batch fermen-
tations were cultured in the medium containing 15  g/L 
glucose, 12 g/L tryptone, 8 g/L yeast extract, 2.1 g/L cit-
ric acid·H2O, 2.5  g/L (NH4)2SO4, 0.1  g/L FeCl3, 0.5  g/L 
MgSO4·7H2O, 0.5 g/L K2PO4·3H2O, 3 g/L KH2PO4, and 
15.13 g/L Na2HPO4·12H2O. Appropriate antibiotics were 
added at the following concentrations: 50  μg/mL kana-
mycin, 34 μg/mL chloramphenicol and 40 μg/mL strep-
tomycin. All media were heat-sterilized at 121 °C for 
15 min.
A seed inoculum of 500 μL from an overnight 5 mL LB 
culture was added to a 500 mL flask containing 100 mL 
of corresponding medium for propagation at 37 °C with 
orbital shaking at 200 rpm. When the OD600 reached 0.6, 
IPTG (0.1 mM) was added to induce protein expression 
at 25 °C and growth continued for 48 h, after which the 
titer of l-lysine and l-PA was measured.
Fed-batch fermentation was carried out in a 7.5 L fer-
mentor (BioFio 115, New Brunswick Scientific, Edi-
son, NJ, USA) with an initial broth volume of 3 L. The 
culture pH was monitored by using a Mettler electrode 
and maintained at 7.0 with the addition of concentrated 
ammonium hydroxide (25% w/w NH3). The dissolved 
oxygen (DO) content was monitored using a Mettler 
oxygen electrode and was maintained at about ~15% by 
adjusting the agitation speed and aeration. Once the ini-
tial glucose was exhausted, glucose (700 g/L) and organic 
nitrogen sources (tryptone, 20 g/L, yeast extract, 15 g/L) 
feeding was initiated. The residual glucose concentration 
was monitored off-line by SBA-40C biosensor analyzer 
and maintained at 5  g/L by adjusting the pump feeding 
rate manually. IPTG (0.1 mM) was added when the OD600 
reached 8–10, and culturing continued for 72 h. Samples 
were removed for measuring cell growth and the concen-
tration of l-lysine and l-pipecolic acid every 2–12 h.
Analytical methods
The DCW was computed from a curve of optical density 
measured at 600 nm (OD600) with respect to dry weight. 
An OD600 of 1.0 represented 45 mg dry weight per liter. 
The concentration of glucose and l-lysine was analyzed 
using a SBA-40C biosensor analyzer [23] (Shandong 
Province Academy of Sciences, Jinan, China) as previ-
ously described. The protein expression were examined 
by SDS-PAGE. Firstly, the cells were harvested and con-
centrated to OD600 = 10. After ultrasonic decomposition 
and centrifugation, the supernatant and the precipitation 
were mixed with protein loading buffer (Takara, Dalian, 
China), 99 °C denatured for 10 min for loading the gel.
The exact l-PA and l-lysine concentrations were deter-
mined using high-performance liquid chromatography 
after labelling with phenylisothiocyanate (PITC) [24], 
using a 1290 apparatus(Agilent Technologies, USA) 
equipped with a C18 column (5 μm, 250 mm × 4.6 mm, 
Grace, USA) at room temperature. Mobile phase A con-
sisted of 7% (v/v) acetonitrile in 0.1  M sodium acetate 
aqueous solution, and mobile phase B consisted of 80% 
(v/v) acetonitrile in water. PITC derivatives were sepa-
rated with a gradient of 97:3 to 30:70 (v/v) of A: B over 
50 min and detected at an absorbance of 254 nm.
The intracellular NAD+, NADH, NADP+ and NADPH 
concentration was measured using dedicated quantifica-
tion kits purchased from Sigma-Aldrich. The content of 
NAD+ and NADH bound to purified LCD was estimated 
using an HPLC method based on that described previ-
ously by Yuan and Borchardt [25]. A quantity of 200 µL 
of an 100  µM solution of purified LCD (20  nmol) was 
precipitated with 3 volumes of 95% ethanol. Supernatants 
were flash-frozen in liquid N2 and lyophilized for 12  h. 
The residue was dissolved in 100  µL of water and ana-
lysed by HPLC (Agilent 1290 Technologies, USA) using a 
C18 column (5 μm, 250 mm × 4.6 mm, Grace, USA) with 
monitoring at 260 and 340 nm. NAD+ and NADH were 
separated under isocratic conditions with 2.5% methanol 
in 0.1 M sodium phosphate buffer (pH 7.0) [18]. Standard 
curves were generated with authentic NAD+ and NADH 
to correlate peak area with the amount of cofactor.
Results
Construction of a metabolic pathway for conversion 
of l‑lysine to l‑PA
To expand the metabolic pathway and include l-pipec-
olic acid as a metabolite, we introduced a unique enzyme 
into the E. coli (Fig. 2a, b) [19]. The pipA gene from Strep-
tomyces pristinaespiralis ATCC25486 encoding the lysine 
cyclodeaminase was amplified and cloned into the vec-
tor pET-28a to generate the recombinant plasmid pET-
28a-pipA followed by the transformation to the E. coli 
BL21(DE3). Further, to investigate the catalytic activity 
of LCD, the cells were cultured, induced at 37  °C with 
1 mM IPTG for 6 h and concentrated to 5 gDCW/L. The 
results showed that with an addition of 1 g/L l-lysine to 
the whole-cell E. coli biocatalyst and crude enzyme liquid 
extracted from same concentration of whole-cell biocata-
lyst, 0.24 and 0.15  g/L l-PA was obtained, respectively, 
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which confirmed the ability of the engineered strain to 
convert l-lysine to l-PA.
However, this relatively low bioconversion rate indi-
cated that the overexpression of LCD in E. coli was 
not optimal and SDS-PAGE analysis confirmed that a 
large fraction of the overexpressed enzyme was pre-
sent in insoluble inclusion body form (Fig.  2c, Lane 1). 
To increase the soluble expression of LCD in E. coli, the 
induction temperature was lowered to 25 °C to avoid the 
rapid generation of the recombinant protein which might 
cause the insolubility. As shown in Fig. 2c Lane 6, slightly 
decrease in inclusion body was observed. Next, five dif-
ferent IPTG concentrations ranging from 0.1 to 1.0 mM 
were tested to induce the LCD expression (Fig. 2c Lanes 
2–6), and 0.5 mM IPTG was optimal (~two to threefold 
higher than controls, Fig.  2c Lanes 1,  4). This change 
increased the bioconversion from l-lysine to l-PA to 45 
and 41% using whole-cell and crude enzyme systems, 
respectively, which was 87.5 and 173% higher than before 
optimization. However, despite the successful overex-
pression and considerable enzymatic activity, l-PA was 
not detectable in shake flask fermentations using mini-
mal media (Fig.  2c), possibly due to the absence of the 
direct precursor of LCD.
Amplification of the l‑lysine precursor metabolic flux
l-Lysine acts as the direct and the only precursor for l-
PA, and therefore plays the key role in l-PA accumula-
tion. To increase l-lysine production, four genes (dapA, 
lysA, lysC, and ddh) from l-lysine metabolic pathways in 
either E. coli or C. glutamicum were over-expressed in E. 
coli BL21(DE3) using pCWJ vectors under the control 
of the trc promoter. Strains harboring different plasmids 
were cultured in the shake flasks containing minimal 
media for 48  h. The results (Fig.  3a) showed that the 
growth of strains was not seriously affected by the over-
expression of these four genes, since the OD600 value was 
decreased by less than 10%. Compared with the CK con-
trol strain, a dramatic increase in lysine titer was achieved 
upon over-expression of dapA, which reaches 0.24  g/L 
with a specific productivity (g lysine/gDCW) of 0.13. In 
addition, the lysC and lysA had a similar positive effect on 
the lysine accumulation, leading to the lysine titer of 0.05 
and 0.07  g/L, respectively. However, the ddh gene from 
the C. glutamicum was less effective, with a lysine titer of 
only 0.03 g/L and a specific productivity of <0.02.
To further improve the production of the lysine, the 
combining over-expression of dapA, lysC, lysA and ddh 
were conducted. Based on the results of the single gene 
Fig. 2 The metabolic pathway of l-pipecolic acid and the heterologous expression the key enzyme LCD. a The pathway and the strategies for 
metabolic engineering for l-pipecolic acid overproduction. The genes represented in red indicate increased flux by directly overexpression in the 
final recombinant strain E. coli BL21–dapA–lysC–lysA–pntAB–pipA. Enzymes encoded by the genes shown are: asd, aspartate semialdehyde dehy-
drogenase; dapA, dihydrodipicolinate synthase; dapB, dihydrodipicolinate reductase; dapC, N-succinyldiaminopimelate-aminotransferase; dapD, tet-
rahydrodipicolinate succinylase; dapE, N-succinyl-l-diaminopimelate desuccinylase; dapF, diaminopimelate epimerase; ddh, meso-diaminopimelate 
dehydrogenase from C. glutamicum; lysA, diaminopimelate decarboxylase; lysC, aspartate kinase III. b The detailed LCD catalytic process. The disas-
sociated amine group are represented in red. c The heterologous expression of the key enzyme LCD. The over expressed LCD is about ~39 kD. Lane 
group 1 37 °C induced with 1 mM IPTG; Lane group 2 25 °C induced with 0.1 mM IPTG; Lane group 3 25 °C induced with 0.3 mM IPTG, Lane group 4 25 
°C induced with 0.5 mM IPTG; Lane group 5 25 °C induced with 0.7 mM IPTG; Lane group 6 25 °C induced with 1 mM IPTG. The proteins in sediment is 
analyzed on the left while the protein in supernatant is analyzed on the right in every lane group
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screening, dapA was considered the most essential gene 
for co-expression and five different combinations includ-
ing dapA–lysC, dapA–lysA, dapA–ddh, dapA–lysC–
lysA and dapA–lysC–lysA–ddh were over-expressed in 
BL21(DE3) using pCWJ vectors under the control of the 
trc promoter. Culturing of these strains in shake flasks 
with minimal media for 48  h resulted in a decrease in 
cell growth with an increasing number of genes over-
expressed (Fig.  3b). The growth of recombinant strain 
BL21–dapA–lysC–lysA–ddh over-expressing all four 
genes was almost half that of CK. However, the growth 
of the other four strains remained over 70% that of CK, 
suggesting over-expressions of three or fewer genes had 
a slight negative effect on cell growth. Co-expression of 
dapA, lysC and lysA resulted in the highest lysine pro-
duction, with a titer and specific productivity of 0.69 g/L 
and 0.49 (g/gDCW), respectively, 2.76-fold higher than the 
single over-expression strain BL21-dapA. In addition, 
lysine production by BL21–dapA–lysC–lysA–ddh was 
only 0.19  g/L, which was slightly lower than the BL21–
dapA, suggesting the further over-expression of ddh 
without optimization of the whole biosynthesis pathway 
might lead to an unbearable burden for the host strain.
According to our previous studies, the LCD activ-
ity might be inhibited by excessive lysine [19], thus, the 
pET-28a–pipA was not only transformed into highest 
lysine production strain BL21–dapA–lysC–lysA, but 
also BL21–dapA and BL21–dapA–lysC that still produce 
a considerable amount of lysine. Recombinant strains 
were cultured in the shake flasks with minimal media for 
48 h, and l-PA was biosynthesized in all strains provided 
the precursor lysine was produced (Fig.  3c), confirming 
the crucial role of the lysine pathway engineering in l-
PA biosynthesis. In general, substrate inhibition did not 
occur at the l-lysine concentrations employed and the 
l-lysine was totally consumed in all strains. l-PA titer 
increased with the increasing lysine concentration up 
to 0.39 g/L, with a yield (relative to lysine) of 0.57 g/g in 
the strain BL21–dapA–lysC–lysA–pipA. Heterologous 
expression of LCD and improvement of the lysine flux 
were therefore successful for engineering E. coli to pro-
duce l-PA from glucose. BL21–dapA–lysC–lysA–pipA 
was the highest l-PA production strain, and was used in 
subsequent experiments.
Rebalancing of the intracellular nicotinamide 
concentration by introducing PNTs
The metabolic pathway of l-PA production requires 
NAD+ as a cofactor for LCD. Although the NAD+ and 
NADH can be recycled in situ, the LCD can only be acti-
vated by the redox state of the nicotinamide (our unpub-
lished work). In addition, According to Walsh et al., LCD 
was incompletely loaded with nicotinamide cofactors 
(NAD+ and NADH) by 50% when overproduced in E. 
coli, and only a third of molecules contained NAD+, sug-
gesting LCD activity may be sensitive to the intracellular 
cofactor concentration [18].
A membrane-bound PNT transhydrogenase encoded 
by pntAB gene has been described previously and used 
for the regeneration of NAD+ and NADPH [26]. The 
PNT enzymes are composed of α and β subunits encoded 
by pntA and pntB genes that catalyze the reduction of 
NADP+ to NADPH via oxidation of NADH to NAD+: 
NADPH + NAD+⇌NADP+ +  NADH [27]. Herein, 
PNTs were introduced into the BL21–dapA–lysC–lysA–
pipA strain to rebalance the nicotinamides and enhance 
LCD activity. As summarized in Table 1, the intracellular 
concentration of NAD+, NADH, NADP+, NADPH and 
their ratios were measured in recombinant cells during 
the exponential growth phase. Although PNTs had tiny 
effect on the NADH/NAD+ ratio, it dramatically lowered 
the NADPH/NADP+  ratio by 37.8%, indicating a redis-
tribution of the nicotinamide content in the engineered 
strains. Although no significant differences in total 
Table 1 Intracellular concentrations of  NAD+, NADH, NADP+, and  NADPH in  recombinant cells during  exponential 
growth
Strains Intracellular concentrations (μmol/gdcw) NADH/NAD
+ ratio NADPH/NADP+ ratio
NAD+ NADP+ NADH NADPH Total
PA 1.54 ± 0.04 0.14 ± 0.02 0.35 ± 0.02 0.73 ± 0.03 2.76 ± 0.05 0.22 ± 0.02 5.21 ± 0.05
PA-PNTs 1.89 ± 0.07 0.13 ± 0.01 0.39 ± 0.01 0.42 ± 0.03 2.83 ± 0.06 0.20 ± 0.01 3.23 ± 0.03
(See figure on previous page.) 
Fig. 3 Gene screening for increasing the biosynthetic pool of precursor l-lysine. The concise descriptions of the genes and plasmid construction 
strategy are on the left with the corresponding results on the right. The filled bar represents OD600, the bar with forward slash represents l-lysine titer 
(g/L), the bar with backslash represents l-pipecolic acid titer (g/L), the bar with horizontal lines represents l-lysine specific productivity (glysine/g DCW), 
the unfilled bar represents l-pipecolic acid specific productivity (g l-PA/g DCW). a Screening of single genes for improving the l-lysine metabolic flux. 
b Screening of gene combinations for improving the l-lysine metabolic flux. c Screening of gene combinations for l-pipecolic acid overproduction
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nicotinamides were observed between the two strains, 
the four nicotinamides were present at different con-
centrations. The presence of PNTs increased the NAD+ 
concentration remarkably by 22.7% and the NADH con-
centration increased slightly leading to a accumulation of 
NAD+/NADH pool. However, the NADPH concentra-
tion decreased slightly, while the NADP+ concentration 
remained at a relatively stable levels. An HPLC method 
used to separate NAD+ from NADH reported by Walsh 
et al. was applied to 20 nmol LCD purified from BL21–
dapA–lysC–lysA–pipA and BL21–dapA–lysC–lysA–
pntAB–pipA. As shown in Fig. 4a, an over-expression of 
PNTs significantly increased the concentration of NAD+ 
bound to LCD, and slightly decreased the NADH bound 
LCD concentration. To conclude, 0.23  mol NAD+/mol 
LCD and 0.29  mol NADH/mol LCD was obtained with 
the strains expressing PNTs, which is 24.3% higher and 
8.4% lower than without expressing PNTs, respectively. 
Further, the recombinant strains were cultured in modi-
fied LB medium for 48  h after induction, and with the 
over-expression of PNTs, the l-PA titer was increased 
35.9% compared with BL21–dapA–lysC–lysA–pipA, 
reached 0.53 g/L (Fig. 4b).
Effect of Fe2+ and surfactant on l‑PA fermentation
Combining the improved precursor l-lysine flux and 
rebalanced nicotinamide cofactor content resulted in 
recombinant strain BL21–dapA–lysC–lysA–pntAB–pipA 
that displayed significantly enhanced l-PA production. 
To further optimize production, fermentation conditions 
were investigated. According to Tsotsou et  al., Fe2+ can 
stimulate the LCD enzyme activity by 13-fold [28]. How-
ever, excess metal ions might inhibit enzyme activity or 
cell growth as well [19]. Therefore, in the present study, 
we investigated the effect of the Fe2+ concentration on 
BL21–dapA–lysC–lysA–pntAB–pipA fermentation. 
As shown in Fig.  5a, the l-PA titer increased with the 
increasing Fe2+ concentration between 0.1 and 1  mM, 
but inhibition was observed at 2 mM, at which the OD600 
and l-PA titer decreased 16.4 and 29.3% respectively in 
comparison with CK. Supplementation with 1 mM Fe2+ 
increased the l-PA titer to 0.68 g/L.
In the fermentation process, metabolites are produced 
intracellularly and excreted from cells via transporters, 
but no transporter of l-PA has been identified to our 
knowledge. Nevertheless, through our previous stud-
ies, excessive l-PA might inhibit LCD activity [19]. Thus, 
the transport of l-PA should be improved. In general, 
the barrier permeability of cells can be altered, and the 
mobility of intra/extracellular substrates and products 
can be improved upon the addition of surfactants dur-
ing fermentation. In the present study, five commonly 
used surfactants were tested (Fig.  5b). While no obvi-
ous change in l-PA titer was observed upon addition of 
CTAB, sorbitol, or Tween-80, supplementation of 1 mM 
DMSO decreased the l-PA titer by two-thirds to only 
0.20 g/L. However, an l-PA titer of 0.64 g/L was obtained 
upon addition of 1 mM Triton X-100, which was 12.3% 
higher than in CK, indicating an improvement in the 
mass transfer of l-PA through the cell membrane.
Fig. 4 Effect of over-expressing PNTs on l-pipecolic acid production. a The HPLC analysis of the NAD+/NADH bound to LCD that over-expressed 
with PNTs or without PNTs. The red line represents the LCD that over-expressed with PNTs, the blue dashed line represents the LCD that over-
expressed without PNTs. The peak at 14.2 min is NAD+ and the peak at 16.9 min is NADH. b The effect of over-expressing PNTs on l-pipecolic acid 
production. The unfilled square represents l-pipecolic acid titer of strain without over-expressing PNTs, the filled circle represents l-pipecolic acid titer 
of strain with over-expressing PNTs (g/L); the cross represents OD600 of stain without over-expressing PNTs, the unfilled diamond represents OD600 of 
stain with over expressing PNTs
Page 8 of 11Ying et al. Microb Cell Fact  (2017) 16:52 
Enhanced l‑PA production by fed‑batch fermentation
To further characterize the optimized strain and explore 
fermentation conditions, BL21–dapA–lysC–lysA–pntAB 
and BL21–dapA–lysC–lysA–pntAB–pipA were cultured 
in a 7.5  L NBS bioreactor with the addition of 1  mM 
FeSO4 and 1 mM Triton X-100 (Fig. 6a, b). The fermen-
tation process involved a two-phase temperature regime, 
with the first phase maintained at 37 °C until the OD600 
reached 8~10 (not shown in the Fig.  6), which usually 
took 6~8 h with an initial inoculum of 10%. In the second 
phase, the temperature was adjusted to 25 °C and 0.5 mM 
IPTG was added to the media to induce over-expression 
of LCD and lysine metabolism pathway enzymes. The 
initial glucose concentration of 15  g/L was exhausted 
shortly after induction, and supplementation of 70% glu-
cose was started straight after to maintain the residual 
glucose concentration as ~5 g/L.
As shown in Fig.  6a, the OD600 of the BL21–dapA–
lysC–lysA–pntAB increased continuously after the cold 
induction and finally reached 19.4 with a lysine titer of 
5.45  g/L after a 48  h induction and maintained till the 
end of the fermentation. On the other hand, with an 
over-expression of LCD in the strain BL21–dapA–lysC–
lysA–pntAB, the biomass was slightly less (OD600 =  18) 
after a 5  h induction, suggested overexpression of LCD 
was not overly harmful to cell growth. In this strain, the 
lysine concentration increased between 0 and 8  h after 
induction, then decreased as a l-PA accumulated after 
Fig. 5 Effect of Fe2+ and surfactant on l-pipecolic acid fermentation. The filled bar represents OD600, the bar with backslash represents l-pipecolic 
acid titer (g/L), the unfilled bar represents l-pipecolic acid specific productivity (g l-PA/g DCW). a The effect of Fe
2+ on l-pipecolic acid fermentation. b 
The effect of surfactant on l-pipecolic acid fermentation
Fig. 6 Enhanced l-pipecolic acid production via fed-batch fermentation. The unfilled square represents OD600, the filled triangle represents l-lysine 
titer (g/L), the filled square represents l-pipecolic acid titer (g/L). a The l-lysine production using BL21–dapA–lysC–lysA–pntAB via fed-batch fermenta-
tion. b The l-pipecolic acid production using BL21–dapA–lysC–lysA–pntAB–pipA via fed-batch fermentation
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8  h. After 36  h, l-PA production slowed slightly, pre-
sumably due to lower precursor l-lysine availability, 
which declined gradually after the exponential phase 
(Fig. 6b). The highest l-lysine concentration (1.5 g/L) was 
observed at 8 h, but this remained below 1 g/L during the 
second half of the fermentation, indicating a relatively 
high lysine consumption rate and efficiency. With a total 
supplement of 120 g (40 g/L) glucose, the l-PA titer and 
yield reached 5.33 g/L and 0.13 g/g glucose, respectively. 
The sum of l-lysine production and l-PA production was 
higher than production of l-lysine alone in the fed-batch 
process, which may be explained by a metabolic pull 
effect [29].
Discussion
The production of single enantiomers of chiral compounds 
or intermediates has become increasingly important in 
the pharmaceuticals industry [1, 2]. l-PA, an important 
chiral precursor for the synthesis of optically pure piperi-
dine rings, forms core structure of many naturally occur-
ring alkaloids and drugs in clinical use [9, 18]. l-PA can 
be biosynthesized using crude enzymes or whole-cell bio-
catalysts [14, 15, 19], and several of the different catalytic 
steps involved have been investigated, including some 
that are unstable and accompanied by high manufacturing 
costs that limit their applications. However, few research-
ers have focused on the direct fermentation of l-PA, even 
though fermentation potentially offers an alternative, 
efficient, low cost method [22]. In the present study, we 
expanded the E. coli metabolic pathway by introducing a 
heterologous lysine cyclodeaminase that can biosynthesize 
l-PA directly from glucose. Furthermore, by improving 
the precursor l-lysine flux and rebalancing the intracel-
lular cofactor concentration, a competitive l-PA titer was 
achieved. To our knowledge, this is the first fermentative 
production of l-PA in a recombinant E. coli host.
Wendisch et  al., previously attempted to develop the 
l-PA producers by engineering the industrial lysine pro-
ducer C. glutamicum to fermentatively synthesized l-PA 
from glucose via the P6C pathway through heterologous 
expression of lysine dehydrogenase (lysDH) and pyrroline 
5-carboxylate reductase (proC) [22]. Although they fully 
optimized the glucose uptake system and achieved an 
acceptable level of by-product elimination, the l-PA titer, 
yield and productivity were low (below 1.9 g/L or 15 mM, 
0.1 g/g and 0.05 g/L h, respectively). The major factor may 
be the complicated metabolic process involved in the con-
version of l-lysine to l-PA, which employs two enzymes 
and an spontaneous reaction. To further complicate mat-
ters, the two enzymes require both NAD+ and NADPH 
co-factors. In addition to the P6C route, however, lysine 
cyclodeaminase offers an alternative method for fermenta-
tive l-PA production. Advantages include fewer enzymatic 
steps and thus the potential for faster growth of the recom-
binant strain and more efficient protein production. Addi-
tionally, LCD might be more efficient at converting lysine 
in vivo and therefore lowering the intracellular concentra-
tion to alleviate potential feedback inhibition.
For the efficient biosynthesis of the l-PA, a high meta-
bolic flux of the direct precursor l-lysine is important. 
Diverse l-lysine biosynthetic pathways exist among dif-
ferent species [29]. In the bacteria, l-lysine is derived 
from l-aspartate via the DAP pathway. In different bac-
terial species, the first steps (dapA) and the last step 
(lysA) are shared when l-lysine was synthesize from 
l-aspartate semialdehyde. There are three pathways asso-
ciated with these steps: a succinylase pathway involving 
succinylated intermediates, an acetylase pathway, and a 
dehydrogenase (ddh) pathway. C. glutamicum has both 
the succinylase and dehydrogenase pathways, whereas 
E. coli possesses only the former pathway. In the present 
study, four genes (dapA, lysA and lysC from E. coli, and 
ddh from C. glutamicum) were evaluated for their lysine 
synthesis ability. The combined over-expression of dapA, 
lysA and lysC provided the highest lysine accumulation. 
However, integration of the more efficient dehydrogenase 
pathway into E. coli did not increase l-lysine and l-PA 
production in the engineered strain, similar results were 
obtained in previous researches reported by Lee et  al. 
and Cremer et al. [29, 30]. They noted that the differences 
in nitrogen affinity between the two pathways affected 
the relative flux and suppressed the ddh pathway. We 
also hypothesis that the less efficiency of the ddh path-
way might be due to the limited supply of the upstream 
precursor oxaloacetate. Further metabolic engineering of 
central metabolic pathways might solve this problem.
The catalytic efficiency of LCD has been described as 
poor by various researches [22]. For example, Wendisch 
et  al. noted that in comparison with the P6C pathway, 
the relatively low turnover number of LCD may limit l-
PA biosynthesis. Previous chromatographic analysis of 
the denatured LCD by Walsh et  al. indicated that LCD 
is initially folded into three forms: apo, NAD+-bound, 
and NADH-bound. However, only 1/6 of the LCD was in 
the NAD+-bound form and possessed fully activity [18]. 
Since the cofactors are incorporated during the protein 
folding process (our unpublished work), rebalancing the 
nicotinamide pool may improve the intracellular NAD+ 
concentration and its incorporation into LCD. The pntAB 
enzyme uses the electrochemical proton gradient as a 
driving force for the reduction of NADP+ to NADPH by 
oxidation of NADH to NAD+, and this is linked to many 
systems. For example, Bott et al. heterologously expressed 
the PNTs in the C. glutamicum, which enhanced the 
l-lysine formation [31], and Xu et al. over-expressed the 
native PNTs in E. coli to enhance the in situ regeneration 
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of NAD+-NADPH [26]. In the present study, over-expres-
sion of PNTs also stimulated the efficient conversion 
of NADP+ and NADH to NAD+ and NADPH, which 
resulted in a 22.7% increase in NAD+ concentration and 
a 35.9% improvement in the l-PA titer. However, a 42.4% 
decrease in the NADPH concentration was also observed, 
but even though 4 mol of NADPH are required per mol 
of lysine in the lysine biosynthesis pathway starting from 
oxaloacetate, this decrease in the NADPH concentration 
did not significantly influence the l-PA accumulation in 
the recombinant E. coli strain. This may be due to several 
reasons: firstly, lysine pathway genes dapA, lysC and lysA 
are not NADPH dependent, and thus not sensitive to a 
decrease in NADPH; secondly, since two more supple-
mentary NADPH pathways are present in E. coli, the effi-
cient in vivo conversion of l-lysine to l-PA might involve 
pulling metabolic flux through the l-lysine biosynthesis 
pathway using NADPH from alternative sources to allevi-
ate the NADPH deficiency caused by PNTs. In particular, 
expression of PNTs might improve the uptake of carbon 
sources, which might also benefit final product forma-
tion [31]. In addition to increasing the intracellular NAD+ 
concentration, Fe2+ is reported to stimulate LCD, and 
exogenous supplementation was therefore investigated 
[28]. Metal ions play a crucial role in protein folding and 
stabilization, as well as the transfer of electrons. Among 
the many transition metals, only iron and copper are used 
in electron transferases. Given that the tightly bound 
NAD+ of LCD may be difficult to rotate during the com-
plex reaction process [18], a possible role for Fe2+ might 
be to assist the electron transfer procedure in this pro-
tein. However, the detailed mechanism of the role of Fe2+ 
requires further structural and computational evidence. 
Supplementation of 1  mM Fe2+ was selected because 
excess Fe2+ would be harmful to cell growth.
Transport of target products through the membrane 
can benefit from metabolic engineering to improve 
export and increase the volumetric productivity. For 
example, lysE is responsible for lysine export, and its 
over-expression can enhance lysine production in the 
lysine producing strain [32]. However, the l-PA transport 
process is still poorly understood. An alternative way to 
improve product transport was therefore attempted by 
adding Triton X-100 as a surfactant, and a concentra-
tion of 1 mM was optimal and increased the l-PA titer by 
17.2%. Fed-batch cultivation of BL21–dapA–lysC–lysA–
pntAB–pipA was performed in a 7.5 L fermentor, result-
ing in efficient l-PA production with almost all l-lysine 
converted to l-PA. In contrast, in a previous l-PA fer-
mentation study by Windisch et  al., the antagonistic 
conversion from glucose to l-lysine and l-lysine to l-PA 
resulted in the incomplete conversion of l-lysine, which 
remained at nearly 20 mM (2.92 g/L).
Conclusions
In the present study, we metabolically engineered an 
E. coli strain to efficiently produce l-PA by enhancing 
l-lysine metabolic pathways, rebalancing the intracellular 
cofactor concentration, and amplifying the key enzyme 
lysine cyclodeaminase. Even though the engineered strain 
excreted 5.33  g/L of l-PA during fed-batch cultivation, 
further strain improvements may be possible to make this 
biotechnological process even more competitive. Removal 
of other lysine degradation and utilization pathways, 
improving the lysine biosynthetic pool, and enhancing the 
tolerance of the strain to product accumulation could all 
lead to further improvements in l-PA production.
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